Qualia Bio was born out of an idea to help ensure patients' access to innovative and life-saving treatments. To champion access, we provide insightful political economics and regulatory support for the biotech and finance industries.
We're here to help manufacturers or investors monetize a therapy's value attributes, integrate government policies, assess a therapy's potential uptake, or assess a drug class's discount or rebate pressure.
We use our in-house and publicly available data to help your biotech business ventures influence and react to policy.
Our actionable data insights, make drug acquisitions and market access straightforward.
Our robust disease burden analytics allow us to bolster your product launch and supply comprehensive health economics insights.
Our regulatory savvy allows us to provide support for your medical device approval.
With our proven regulatory experience, we will support you in demonstrating your products value.
We leverage data insights, software solutions and regulatory knowledge to support your diagnostic’s journey to market.